6. SOPHiA GENETICS S.A. (NASDAQ:SOPH)
SOPHiA GENETICS S.A. (NASDAQ: SOPH) ranks sixth as a small-cap precision medicine company using artificial intelligence to analyze complicated genomic and medical information. Shares traded near $8.09, while the market capitalization stood at approximately $529 million.
The company’s cloud-based platform helps hospitals, laboratories and pharmaceutical organizations interpret genomic data. Its technology is particularly relevant to precision oncology, where understanding the molecular characteristics of a tumor can help doctors select more appropriate treatments.
Healthcare institutions can generate enormous volumes of biological data but may lack the internal technology required to analyze it consistently. The platform is designed to convert that raw information into insights that can support diagnosis, drug development and treatment selection. As more hospitals adopt genomic testing, demand for AI-powered clinical data analysis could expand.
Second-quarter 2026 revenue increased 27% to $23.3 million. Reported gross margin reached 64.6%, while adjusted gross margin was 72.1%. The adjusted EBITDA loss improved 27% to $8.8 million. The complete quarterly performance was published in the company’s financial announcement.
The revenue growth is encouraging, but the company remains far from conventional profitability. Its quarterly net loss totaled $22.4 million, nearly equal to its revenue for the period. This creates an obvious need to continue controlling expenses and preserving cash.
Its relatively small market capitalization creates substantial multibagger potential if the platform becomes a widely adopted part of precision medicine. Still, investors must monitor cash usage, customer growth and dilution carefully. The technology addresses a genuine healthcare need, but the company must prove that strong revenue growth can eventually translate into sustainable earnings.
YOU MUST READ THIS: Top 10 Healthcare Stocks to Buy With $1000 in 2026
Click here to continue reading and checkout the 5 Best Cheap AI Medicine Stocks to Buy Now.
Disclosure: No relevant interests to disclose. This article was originally published on BioTech HealthX.
